Insider Signal

Research · Stream 2 of 2

IPO Toxic Detector — why short, and when.

The second stream of our research desk. Built from a multi-year study of US IPOs, this stream does not chase hot IPO launches — it isolates IPOs that are likely to fail, and frames them as short-side research setups with explicit borrow and liquidity context.

Who we are

Same research desk as Insider Edge. One platform, one VIP membership, two independent research streams with separate Telegram channels so signal types never get mixed up. This page documents the IPO stream.

What we studied

  • Sample

    2,792

    US IPOs in the research set

  • Window

    20+ years

    multiple cycles, not a single regime

  • Iterations

    26 phases

    train / test split — rules are not fit to one window

Development and selection windows were consulted repeatedly across research phases. A genuinely untouched future holdout for final customer performance claims is not claimed here. Treat IPO results as research framing with explicit borrow/liquidity limits — not as a clean out-of-sample validation certificate.

The main finding

Long IPO

No durable buy-side historical finding at IPO

Taken as a population, IPOs do not hold up as long ideas. Aggregate post-IPO drift is negative, and the narrow set that does run up is already priced in by the time retail can participate on equal terms.

Short toxic IPO

The historical research finding shows up on the short side

When a toxic setup is detectable at the structural level (failed breakout, early exhaustion, distribution), short-side historical research findings recur across the long study window. Forward validation is still required before any customer performance claim. This stream is research context — not an executable strategy guarantee.

Put differently: the IPO market behaves much closer to a distribution market than an accumulation market. The stream is designed around that fact — it surfaces only setups where the short-side thesis is both structurally present and executable.

What we look for

  • Failed breakout

    Post-IPO push that fails at a structural level, with the subsequent tape showing rejection rather than consolidation.

  • Early exhaustion

    Narrow early run into weakening participation, often visible in breadth and tape characteristics before price breaks.

  • Weak continuation

    Up-moves that lack follow-through. The pipeline favors setups where the stock cannot reclaim prior highs on comparable flow.

  • Distribution / volume problems

    Volume patterns inconsistent with accumulation — wide spreads into rallies, tighter spreads on weakness, and unlock-adjacent liquidity shifts.

What you get as a user

  • VIP

    Dedicated IPO Toxic Detector VIP Telegram channel. Full /ipo list and detail pages. Verdict, score, reasons, timing, borrow / HTB context and the SEC primary-source link on every row. Daily VIP cap to keep noise low.

  • Public

    Limited delayed teasers in the shared public Telegram channel, rate-limited weekly. Public teasers are marketing — full research lives on VIP.

Honest limits

  • Not every IPO is shortable

    Many IPOs sit on HTB with no locate. Even when the setup is clean, execution can be impossible on your broker for hours or days.

  • Borrow / fees / slippage

    Borrow rates on recent IPOs can be punitive. The per-row detail page reports the pipeline’s borrow APR context — your real cost will differ by broker.

  • Low frequency by design

    The filter is deliberately tight. You’ll see a handful of VIP rows per week at most, not a firehose.

  • Execution depends on broker

    The stream delivers research output, not a filled order. Position sizing, risk, and the final execution decision are yours.

This is research, not financial advice. We never publish a BUY idea on the IPO stream — it is short-side only by design.

Read the actual research output

The live IPO list is the research output. Each row links to a full detail page with reasons, timing, borrow context, and the SEC primary source.